Abstract
Post-stroke depression (PSD) is one of common and serious sequelae of stroke. Approximately, one in three stroke survivors suffered from depression after stroke. It heavily affected functional rehabilitation, which leaded to poor quality of life. What is worse, it is strongly associated with high mortality. In this review, we aimed to derive a comprehensive and integrated understanding of PSD according to recently published papers and previous classic articles. Based on the considerable number of studies, we found that within 2 years incidence of PSD has a range from 11 to 41%. Many factors contribute to the occurrence of PSD, including the history of depression, stroke severity, lesion location, and so on. Currently, the diagnosis of PSD is mainly based on the DSM guidelines and combined with various depression scales. Unfortunately, we lack a unified mechanism to explain PSD which mechanisms now involve dysregulation of hypothalamic–pituitary–adrenal (HPA) axis, increased inflammatory factors, decreased levels of monoamines, glutamate-mediated excitotoxicity, and abnormal neurotrophic response. At present, both pharmacotherapy and psychological therapies are employed in treating PSD. Although great advance has been made by researchers, there are still a lot of issues need to be addressed. Especially, the mechanism of PSD is not completely clear.
Similar content being viewed by others
References
Aben I, Denollet J, Lousberg R, Verhey F, Wojciechowski F, Honig A (2002) Personality and vulnerability to depression in stroke patients—a 1-year prospective follow-up study. Stroke 33:2391–2395
Aliprandi A, Longoni M, Stanzani L, Tremolizzo L, Vaccaro M, Begni B, Galimberti G, Garofolo R, Ferrarese C (2005) Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake. J Cereb Blood Flow Metab 25:513–519
Andersen G, Vestergaard K, Lauritzen L (1994) Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25:1099–1104
Andersen G, Vestergaard K, Riis JO, Lauritzen L (1994) Incidence of poststroke depression during the first year in a large unselected stroke population determined using a valid standardized rating-scale. Acta Psychiatr Scand 90:190–195
Appelros P, Viitanen M (2004) Prevalence and predictors of depression at one year in a Swedish population-based cohort with first-ever stroke. J Stroke Cerebrovasc Dis 13:52–57
Astrom M, Olsson T, Asplund K (1993) Different linkage of depression to hypercortisolism early versus late after stroke—a 3-year longitudinal-study. Stroke 24:52–57
Ayerbe L, Ayis S, Crichton SL, Rudd AG, Wolfe CDA (2014) Explanatory factors for the increased mortality of stroke patients with depression. Neurology 83:2007–2012
Ayerbe L, Ayis S, Rudd AG, Heuschmann PU, Wolfe CDA (2011) Natural history, predictors, and associations of depression 5 years after stroke: the South London Stroke Register. Stroke 42:1907–1911
Ayerbe L, Ayis S, Wolfe CDA, Rudd AG (2013) Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry 202:14–21
Backhouse EV, McHutchison CA, Cvoro V, Shenkin SD, Wardlaw JM (2018) Cognitive ability, education and socioeconomic status in childhood and risk of post-stroke depression in later life: a systematic review and meta-analysis. PLoS ONE 13:15
Baldwin JR, Arseneault L, Caspi A, Fisher HL, Moffitt TE, Odgers CL, Pariante C, Ambler A, Dove R, Kepa A, Matthews T, Menard A, Sugden K, Williams B, Danese A (2018) Childhood victimization and inflammation in young adulthood: a genetically sensitive cohort study. Brain Behav Immun 67:211–217
Barca ML, Eldholm RS, Persson K, Bjorklof GH, Borza T, Telenius E, Knapskog AB, Braekhus A, Saltvedt I, Selbaek G, Engedal K (2019) Cortisol levels among older people with and without depression and dementia. Int Psychogeriatr 31:597–601
Baylan S, Griffiths S, Grant N, Broomfield NM, Evans JJ, Gardani M (2020) Incidence and prevalence of post-stroke insomnia: a systematic review and meta-analysis. Sleep Med Rev 49:16
Beato M, Herrlich P, Schutz G (1995) Steroid-hormone receptors—many actors in search of a plot. Cell 83:851–857
Beck AT, Erbaugh J, Ward CH, Mock J, Mendelsohn M (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Biran I, Chatterjee A (2003) Depression with anosognosia following a left subcortical stroke. Clin Neurol Neurosurg 105:99–101
Camargos QM, Silva BC, Silva DG, Toscano ECD, Oliveira BD, Bellozi PMQ, Jardim BLD, Vieira ELM, de Oliveira ACP, Sousa LP, Teixeira AL, de Miranda AS, Rachid MA (2020) Minocycline treatment prevents depression and anxiety-like behaviors and promotes neuroprotection after experimental ischemic stroke. Brain Res Bull 155:1–10
Carnes-Vendrell A, Deus J, Molina-Seguin J, Pifarre J, Purroy F (2019) Depression and apathy after transient ischemic attack or minor stroke: prevalence, evolution and predictors. Sci Rep 9:9
Castilla-Guerra L, Fernandez Moreno MDC, Esparrago-Llorca G, Colmenero-Camacho MA (2020) Pharmacological management of post-stroke depression. Expert Rev Neurother 20:157–166
Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, Bullmore ET (2019) Treatment-resistant depression and peripheral C-reactive protein. Br J Psychiatry 214:11–19
Chang WH, Shin MA, Lee A, Kim H, Kim YH (2018) Relationship between serum BDNF levels and depressive mood in subacute stroke patients: a preliminary study. Int J Mol Sci 19:8
Chatzistefanidis D, Giannopoulos S, Spengos K, Vassilopoulou S, Vemmos K, Dova L, Vartholomatos G, Kyritsis AP, Georgiou I, Markoula S (2014) Apolipoprotein E polymorphisms and ischaemic stroke: a two-center Greek study. Eur J Neurol 21:1083–1088
Chavez-Castillo M, Nunez V, Nava M, Ortega A, Rojas M, Bermudez V, Rojas-Quintero J (2019) Depression as a neuroendocrine disorder: emerging neuropsychopharmacological approaches beyond monoamines. Adv Pharmacol Sci 2019:20
Chen YP, Mei YW, Sun SG, Bao M, Yu SC (2005) Evaluation of frequency repetitive transcranial magnetic stimulation for post-stroke depression and neurologic impairment. Chin J Clin Rehab 9:18–19
Cheng LS, Tu WJ, Shen Y, Zhang LJ, Ji KX (2018) Combination of high-sensitivity C-reactive protein and homocysteine predicts the post-stroke depression in patients with ischemic stroke. Mol Neurobiol 55:2952–2958
Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, Bejot Y, Deltour S, Jaillard A, Niclot P, Guillon B, Moulin T, Marque P, Pariente J, Arnaud C, Loubinoux I (2011) Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10:123–130
Chourbaji S, Vogt MA, Gass P (2007) Mice that under- or overexpress glucocorticoid receptors as models for depression or posttraumatic stress disorder. In: DeKloet ER, Vermetten E (eds) Stress hormones and post traumatic stress disorder: basic studies and clinical perspectives. Elsevier Science Bv, Amsterdam, pp 65–77
Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. Br Med J 343:15
Cryan JF, Mombereau C (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatr 9:326–357
Dajpratham P, Pukrittayakamee P, Atsariyasing W, Wannarit K, Boonhong J, Pongpirul K (2020) The validity and reliability of the PHQ-9 in screening for post-stroke depression. BMC Psychiatry 20:8
Danese A, Pariante CM, Caspi A, Taylor A, Poulton R (2007) Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA 104:1319–1324
Das J, Rajanikant GK (2018) Post stroke depression: the sequelae of cerebral stroke. Neurosci Biobehav Rev 90:104–114
de Man-van Ginkel JM, Hafsteinsdottir TB, Lindeman E, Ettema RGA, Grobbee DE, Schuurmans MJ (2013) In-hospital risk prediction for post-stroke depression development and validation of the post-stroke depression prediction scale. Stroke 44:2441–2445
De Ryck A, Brouns R, Geurden M, Elseviers M, De Deyn PP, Engelborghs S (2014) Risk factors for poststroke depression: identification of inconsistencies based on a systematic review. J Geriatr Psychiatry Neurol 27:147–158
Devine MJ, Bentley P, Jones B, Hotton G, Greenwood RJ, Jenkins IH, Joyce EM, Malhotra PA (2014) The role of the right inferior frontal gyrus in the pathogenesis of post-stroke psychosis. J Neurol 261:600–603
Disease GBD, Injury I, Prevalence C (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1789–1858
Doolin K, Farrell C, Tozzi L, Harkin A, Frodl T, O’Keane V (2017) Diurnal hypothalamic-pituitary-adrenal axis measures and inflammatory marker correlates in major depressive disorder. Int J Mol Sci 18:17
Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597–606
Duman RS, Sanacora G, Krystal JH (2019) Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 102:75–90
Fang MD, Zhong LL, Jin X, Cui RJ, Yang W, Gao SH, Lv J, Li BJ, Liu TJ (2019) Effect of inflammation on the process of stroke rehabilitation and poststroke depression. Front Psychiatry 10:8
Farrell C, Doolin K, O’Leary N, Jairaj C, Roddy D, Tozzi L, Morris D, Harkin A, Frodl T, Nemoda Z, Szyf M, Booij L, O’Keane V (2018) DNA methylation differences at the glucocorticoid receptor gene in depression are related to functional alterations in hypothalamic-pituitary-adrenal axis activity and to early life emotional abuse. Psychiatry Res 265:341–348
Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15:505–522
Folstein MF, Maiberger R, McHugh PR (1977) Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 40:1018–1020
Frey J, Najib U, Lilly C, Adcock A (2020) Novel TMS for stroke and depression (NoTSAD): accelerated repetitive transcranial magnetic stimulation as a safe and effective treatment for post-stroke depression. Front Neurol 11:7
Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U (2003) Early fluoxetine treatment of post-stroke depression—a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 250:347–351
Gao HQ, Zhu HY, Zhang YQ, Wang LX (2008) Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: a preliminary report. Clin Invest Med 31:E351–E356
Gao J, Lin MQ, Zhao JH, Bi SW, Ni ZY, Shang XL (2017) Different interventions for post-ischaemic stroke depression in different time periods: a single-blind randomized controlled trial with stratification by time after stroke. Clin Rehabil 31:71–81
Goldberg DP, Hillier VF (1979) A scaled version of the General Health Questionnaire. Psychol Med 9:139–145
Grabowska-Fudala B, Jaracz K, Gorna K, Miechowicz I, Wojtasz I, Jaracz J, Kazmierski R (2018) Depressive symptoms in stroke patients treated and non-treated with intravenous thrombolytic therapy: a 1-year follow-up study. J Neurol 265:1891–1899
Hackett ML, Anderson CS (2005) Predictors of depression after stroke - A systematic review of observational studies. Stroke 36:2296–2301
Hackett ML, Kohler S, O’Brien JT, Mead GE (2014) Neuropsychiatric outcomes of stroke. Lancet Neurol 13:525–534
Hackett ML, Pickles K (2014) Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke 9:1017–1025
Hackett ML, Yapa C, Parag V, Anderson CS (2005) Frequency of depression after stroke—a systematic review of observational studies. Stroke 36:1330–1340
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Hamon M, Blier P (2013) Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuro-Psychopharmacol Biol Psychiatry 45:54–63
Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, Lupien SJ, Roozendaal B, Seckl JR (2006) Do corticosteroids damage the brain? J Neuroendocrinol 18:393–411
Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP (1998) The Sunnybrook stroke study—a prospective study of depressive symptoms and functional outcome. Stroke 29:618–624
Jorgensen TSH, Wium-Andersen IK, Wium-Andersen MK, Jorgensen MB, Prescott E, Maartensson S, Kragh-Andersen P, Osler M (2016) Incidence of depression after stroke, and associated risk factors and mortality outcomes, in a large cohort of Danish patients. JAMA Psychiat 73:1032–1040
Juruena MF, Bocharova M, Agustini B, Young AH (2018) Atypical depression and non-atypical depression: is HPA axis function a biomarker ? A systematic review. J Affect Disord 233:45–67
Kalkman HO (2019) Novel treatment targets based on insights in the etiology of depression: role of IL-6 trans-signaling and stress-induced elevation of glutamate and ATP. Pharmaceuticals 12:23
Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM (2018) Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatr 23:335–343
Khan TA, Shah T, Prieto D, Zhang WL, Price J, Fowkes GR, Cooper J, Talmud PJ, Humphries SE, Sundstrom J, Hubacek JA, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Abdollahi MR, Slooter AJC, Szolnoki Z, Sandhu M, Wareham N, Frikke-Schmidt R, Tybjaerg-Hansen A, Fillenbaum G, Heijmans BT, Katsuya T, Gromadzka G, Singleton A, Ferrucci L, Hardy J, Worrall B, Rich SS, Matarin M, Whittaker J, Gaunt TR, Whincup P, Morris R, Deanfield J, Donald A, Smith GD, Kivimaki M, Kumari M, Smeeth L, Khaw KT, Nalls M, Meschia J, Sun K, Hui RT, Day I, Hingorani AD, Casas JP (2013) Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14 015 stroke cases and pooled analysis of primary biomarker data from up to 60 883 individuals. Int J Epidemiol 42:475–492
Khedr EM, Abdelrahman AA, Desoky T, Zaki AF, Gamea A (2020) Post-stroke depression: frequency, risk factors, and impact on quality of life among 103 stroke patients—hospital-based study. Egypt J Neurol Psychiatry Neurosurg 56:1–8
Kim JS, Lee EJ, Chang DI, Park JH, Ahn SH, Cha JK, Heo JH, Sohn SI, Lee BC, Kim DE, Kim HY, Kim S, Kwon DY, Kim J, Seo WK, Lee J, Park SW, Koh SH, Kim JY, Choi-Kwon S, Investigators E (2017) Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study. Lancet Psychiatry 4:33–41
King M, Kelly LP, Wallack EM, Hasan SMM, Kirkland MC, Curtis ME, Chatterjee T, McCarthy J, Ploughman M (2019) Serum levels of insulin-like growth factor-1 and brain-derived neurotrophic factor as potential recovery biomarkers in stroke. Neurol Res 41:354–363
Kohen R, Cain KC, Mitchell PH, Becker K, Buzaitis A, Millard SP, Navaja GP, Teri L, Tirschwell D, Veith R (2008) Association of serotonin transporter gene polymorphisms with poststroke depression. Arch Gen Psychiatry 65:1296–1302
Koreki A, Takahata K, Tabuchi H, Kato M (2012) Increased left anterior insular and inferior prefrontal activity in post-stroke mania. BMC Neurol 12:5
Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9—validity of a brief depression severity measure. J Gen Intern Med 16:606–613
Kutlubaev MA, Hackett ML (2014) Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. Int J Stroke 9:1026–1036
Lanctôt KL, Lindsay MP, Smith EE, Sahlas DJ, Foley N, Gubitz G, Austin M, Ball K, Bhogal S, Blake T, Herrmann N (2020) Canadian stroke best practice recommendations: mood, cognition and fatigue following stroke, 6th edition update 2019. Int J Stroke 15(6):668–688
Lang UE, Hellweg R, Gallinat J (2004) BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 29:795–798
Leonard BE (2018) Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr 30:1–16
Li J, Sha LZ, Xu Q (2020) An early increase in glutamate is critical for the development of depression-like behavior in a chronic restraint stress (CRS) model. Brain Res Bull 162:59–66
Liew SC, Das Gupta E (2015) Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet 58:1–10
Liman TG, Heuschmann PU, Endres M, Floeel A, Schwab S, Kolominsky-Rabas PL (2012) Impact of low mini-mental status on health outcome up to 5 years after stroke: the Erlangen Stroke Project. J Neurol 259:1125–1130
Lincoln NB, Flannaghan T (2003) Cognitive behavioral psychotherapy for depression following stroke— a randomized controlled trial. Stroke 34:111–115
Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR (1984) Nortriptyline treatment of post-stroke depression—a double-blind-study. Lancet 1:297–300
Liu Q, Wang XW, Wang YL, Wang CX, Zhao XQ, Liu LP, Li ZX, Meng X, Guo L, Wang YJ (2018) Association between marriage and outcomes in patients with acute ischemic stroke. J Neurol 265:942–948
Liu X, Wang B, Wang X, Tian M, Zhang Y (2020) Elevated plasma high-sensitivity C-reactive protein at admission predicts the occurrence of post-stroke fatigue at 6 months after ischaemic stroke. Eur J Neurol 27(10):2022–2030
Lobo A, Perezecheverria MJ, Artal J (1986) Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population. Psychol Med 16:135–140
Madeira C, Vargas-Lopes C, Brandao CO, Reis T, Laks J, Panizzutti R, Ferreira ST (2018) Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable Alzheimer’s disease and depression. Front Psychiatry 9:561
Malhi GS, Mann JJ (2018) Depression. Lancet 392:2299–2312
McEwen BS (2004) Protection and damage from acute and chronic stress—allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. In: Yehuda R, McEwen B (eds) Biobehavioral stress response: protective and damaging effects. Annals of the New York Academy of Sciences, pp 1–7
Mead GE, Hsieh CF, Lee R, Kutlubaev M, Claxton A, Hankey GJ, Hackett M (2013) Selective serotonin reuptake inhibitors for stroke recovery a systematic review and meta-analysis. Stroke 44:844
Mijajlovic MD, Pavlovic A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, Hermann DM, Ben Assayag E, Richard E, Thiel A, Kliper E, Shin Y, Kim YH, Choi S, Jung S, Lee YB, Sinanovic O, Levine DA, Schlesinger I, Mead G, Milosevic V, Leys D, Hagberg G, Ursin MH, Teuschl Y, Prokopenko S, Mozheyko E, Bezdenezhnykh A, Matz K, Aleksic V, Muresanu D, Korczyn AD, Bornstein NM (2017) Post-stroke dementia—a comprehensive review. BMC Med 15:12
Mitchell PH, Veith RC, Becker KJ, Buzaitis A, Cain KC, Fruin M, Tirschwell D, Teri L (2009) Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant living well with stroke: randomized, controlled trial. Stroke 40:3073–3078
Mourao AM, Vicente LCC, Abreu MNS, Sant’Anna RV, Vieira ELM, de Souza LC, de Miranda AS, Rachid MA, Teixeira AL (2019) Plasma levels of brain-derived neurotrophic factor are associated with prognosis in the acute phase of ischemic stroke. J Stroke Cerebrovasc Dis 28:735–740
Murray V, von Arbin M, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, Nasman P, Olsson JE, Samuelsson M, Terent A, Varelius R, Asberg M, Martensson B (2005) Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 66:708–716
Nemeroff CB, Vale WW (2005) The neurobiology of depression: Inroads to treatment and new drug discovery. J Clin Psychiatry 66:5–13
Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and TRKB messenger-RNA in rat-brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539–7547
Nicolo JP, O’Brien TJ, Kwan P (2019) Role of cerebral glutamate in post-stroke epileptogenesis. NeuroImage-Clin 24:6
Northcott S, Moss B, Harrison K, Hilari K (2016) A systematic review of the impact of stroke on social support and social networks: associated factors and patterns of change. Clin Rehabil 30:811–831
Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA, Lackland DT, Lichtman JH, Mohl S, Sacco RL, Saver JL, Trogdon JG, American Heart Association Advocacy (2013) Forecasting the future of stroke in the United States a policy statement from the American Heart Association and American Stroke Association. Stroke 44:2361–2375
Pace TWW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, Heim CM (2006) Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiat 163:1630-U1631
Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB (2011) Depression and risk of stroke morbidity and mortality a meta-analysis and systematic review. J Am Med Assoc 306:1241–1249
Paolucci S (2008) Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat 4:145–154
Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464–468
Rachid F, Bertschy G (2006) Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression: a critical appraisal of the last 10 years. Neurophysiol Clin-Clin Neurophysiol 36:157–183
Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
Rahamatali M, De Bont N, Valet M, Halkin V, Hanson P, Deltombe T, Lejeune T, Selves C (2021) Post-stroke fatigue: how it relates to motor fatigability and other modifiable factors in people with chronic stroke. Acta Neurol Belg 121:181–189
Raison CL, Borisov AS, Majer M, Drake DF, Pagnoni G, Woolwine BJ, Vogt GJ, Massung B, Miller AH (2009) Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 65:296–303
Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24–31
Randhawa PK, Bali A, Jaggi AS (2015) RIPC for multiorgan salvage in clinical settings: evolution of concept, evidences and mechanisms. Eur J Pharmacol 746:317–332
Rasmussen A, Christensen J, Clemmensen PM, Dalsgaard NJ, Dam H, Hindberg I, Lunde M, Plenge P, Mellerup E (2003) Platelet serotonin transporter in stroke patients. Acta Neurol Scand 107:150–153
Reichardt HM, Umland T, Bauer A, Kretz O, Schutz G (2000) Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol Cell Biol 20:9009–9017
Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, Zink M, Hortnagl H, Flor H, Henn FA, Schutz G, Gass P (2005) Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 25:6243–6250
Robinson RG, Jorge RE (2016) Post-stroke depression: a review. Am J Psychiat 173:221–231
Robinson RG, Jorge RE, Clarence-Smith K (2008) Double-blind randomized treatment of poststroke depression using nefiracetam. J Neuropsychiatr Clin Neurosci 20:178–184
Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, Fonzetti P, Hegel M, Arndt S (2008) Escitalopram and problem-solving therapy for prevention of poststroke depression—a randomized controlled trial. J Am Med Assoc 299:2391–2400
Robinson RG, Kubos KL, Starr LB, Rao K, Price TR (1984) Mood disorders in stroke patients—importance of location of lesion. Brain 107:81–93
Robinson RG, Price TR (1982) Post-stroke depressive-disorders—a follow-up-study of 103 patients. Stroke 13:635–641
Robinson RG, Spalletta G (2010) Poststroke depression: a review. Can J Psychiat-Rev Can Psychiat 55:341–349
Robinson RG, Szetela B (1981) Mood change following left hemispheric brain injury. Ann Neurol 9:447–453
Sachdev PS (2018) Post-stroke cognitive impairment, depression and apathy: untangling the relationship. Am J Geriatr Psychiatr 26:301–303
Salter KL, Foley NC, Zhu L, Jutai JW, Teasell RW (2013) Prevention of poststroke depression: does prophylactic pharmacotherapy work? J Stroke Cerebrovasc Dis 22:1243–1251
Sanner J, Montiel TC, Cron SG, Leal AA, Baltazar N, Hinojosa E, Okpala M, Savitz S, Sharrief AZ (2019) Identifying and understanding factors associated with post-stroke anxiety. Stroke 50:2
Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, Suridjan I, Kennedy JL, Rekkas V, Houle S, Meyer JH (2015) Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiat 72:268–275
Sheehan DV, Janavs J, Baker R, Harnett-Sheehan K, Knapp E, Sheehan M, Lecrubier Y, Weiller E, Hergueta T, Amorim P, Bonora LI, Lepine JP (1998) MINI—mini international neuropsychiatric interview—English version 5.0.0—DSM-IV. J Clin Psychiatry 59:34–57
Shen XY, Liu MY, Cheng Y, Jia C, Pan XY, Gou QY, Liu XL, Cao H, Zhang LS (2017) Repetitive transcranial magnetic stimulation for the treatment of post-stroke depression: a systematic review and meta-analysis of randomized controlled clinical trials. J Affect Disord 211:65–74
Shi KB, Tian DC, Li ZLG, Ducruet AF, Lawton MT, Shi FD (2019) Global brain inflammation in stroke. Lancet Neurol 18:1058–1066
Shi Y, Yang D, Zeng Y, Wu W (2017) Risk factors for post-stroke depression: a meta-analysis. Front Aging Neurosci 9:218
Shi Y, Yang DD, Zeng YY, Wu W (2017) Risk factors for post-stroke depression: a meta-analysis. Front Aging Neurosci 9:14
Sienkiewicz-Jarosz H, Milewska D, Bochynska A, Chelmniak A, Dworek N, Kasprzyk K, Galecka K, Szczepanska-Szerej A, Chwojnicki K, Zyluk B, Slowik A, Ryglewicz D (2010) Predictors of depressive symptoms in patients with stroke—a three-month follow-up. Neurol Neurochir Pol 44:13–20
Smi CK, Han SW, Kwon SU, Kang DW, Choi JM, Kim JS (2006) Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness a double-blind, placebo-controlled study. Stroke 37:156–161
Smith MA, Makino S, Kvetnansky R, Post RM (1995) Effects of stress on neurotrophic factor expression in the rat brain. In: Chrousos GP, McCarty R, Pacak K, Cizza G, Sternberg E, Gold PW, Kvetnansky R (eds) Stress: basic mechanisms and clinical implications. New York Acad Sciences, New York, pp 234–239
Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35:298–306
Spindelegger CJ, Papageorgiou K, Grohmann R, Engel R, Greil W, Konstantinidis A, Agelink MW, Bleich S, Ruether E, Toto S, Kasper S (2015) Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. Int J Neuropsychopharmacol 18(4):pyu080
Spitzer RL, Kroenke K, Williams JBW, Patient Hlth Questionnaire P (1999) Validation and utility of a self-report version of PRIME-MD—the PHQ primary care study. J Am Med Assoc 282:1737–1744
Stockmeier CA (2003) Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 37:357–373
Sturm JW, Donnan GA, Dewey HM, Macdonell RAL, Gilligan AK, Thrift AG (2004) Determinants of handicap after stroke - The North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 35:715–720
Taylor-Rowan M, Momoh O, Ayerbe L, Evans JJ, Stott DJ, Quinn TJ (2019) Prevalence of pre-stroke depression and its association with post-stroke depression: a systematic review and meta-analysis. Psychol Med 49:685–696
Tsai CS, Wu CL, Hung TH, Chou SY, Su JA (2016) Incidence and risk factors of poststroke depression in patients with acute ischemic stroke: a 1-year prospective study in Taiwan. Biomed J 39:195–200
Vanpraag HM, Korf J (1973) Cerebral monoamines and depression—investigation with probenecid technique. Arch Gen Psychiatry 28:827–831
Vataja R, Pohjasvaara T, Leppavuori A, Mantyla R, Aronen HJ, Salonen O, Kaste M, Erkinjuntti T (2001) Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry 58:925–931
Villa RF, Ferrari F, Moretti A (2018) Post-stroke depression: mechanisms and pharmacological treatment. Pharmacol Ther 184:131–144
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang ALR, Cheng SS, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah STH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW, American Heart Association (2020) Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 141:E139–E596
Whyte EM, Mulsant BH (2002) Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 52:253–264
Williams CL, Rittman MR, Boylstein C, Faircloth C, Qin HJ (2005) Qualitative and quantitative measurement of depression in veterans recovering from stroke. J Rehabil Res Dev 42:277–290
Wilson KCM, Mottram PG, Vassilas CA (2008) Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev 36(1):CD004853
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1983) Development and validation of a geriatric depression screening scale—a preliminary-report. J Psychiatr Res 17:37–49
Yi ZM, Liu F, Zhai SD (2010) Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis. Int J Clin Pract 64:1310–1317
Zhang E, Liao P (2020) Brain-derived neurotrophic factor and post-stroke depression. J Neurosci Res 98:537–548
Zhang WN, Pan YH, Wang XY, Zhao Y (2013) A prospective study of the incidence and correlated factors of post-stroke depression in China. PLoS ONE 8:5
Zhao FY, Yue YY, Jiang HT, Yuan YG (2019) Shared genetic risk factors for depression and stroke. Prog Neuro-Psychopharmacol Biol Psychiatry 93:55–70
Zhao FY, Yue YY, Zhang SN, Zhang KZ, Shi YY, Zhang XM, Cao Y, Cao JX, Li HJ, Wu YF, Feng YR, Zhao Z, Pan NF, Sheng L, Geng DQ, Wu AQ, Yang Y, Tang H, Lu JX, Zuo XB, Yuan YG (2019) Novel susceptibility genes were found in a targeted sequencing of stroke patients with or without depression in the Chinese Han population. J Affect Disord 255:1–9
Zhao WB, Jiang F, Zhang Z, Zhang J, Ding YC, Ji XM (2017) Remote ischemic conditioning: a novel non-invasive approach to prevent post-stroke depression. Front Aging Neurosci 9:4
Zhou WJ, Ye SD, Luo R, Wu LM, Wang W (2019) Inhibition of acid-sensing ion channels reduces the hypothalamus-pituitary-adrenal axis activity and ameliorates depression-like behavior in rats. RSC Adv 9:8707–8713
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370
Acknowledgements
This work was supported by National Natural Science Foundation of China (Nos. U20A20357), and “The Fundamental Research Funds for the Central Universities”.
Funding
This work was supported by National Natural Science Foundation of China (Nos. U20A20357), and “The Fundamental Research Funds for the Central Universities”.
Author information
Authors and Affiliations
Contributions
XL and WS designed the study. JG wrote the manuscript. JW and WS revised the manuscript. All the authors contributed to and have approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interests.
Rights and permissions
About this article
Cite this article
Guo, J., Wang, J., Sun, W. et al. The advances of post-stroke depression: 2021 update. J Neurol 269, 1236–1249 (2022). https://doi.org/10.1007/s00415-021-10597-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-021-10597-4